CureVac Company Contacts

CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. The principle of CureVac’s proprietary... Read More

Contacts

Country

Germany

City

Tübingen

Headquarters

Tübingen, Baden-Württemberg

Profile

Founded

2000

Industry

Biotechnology Research

Size

1001 - 5000

Specialties

mRNA therapeutics, cancer therapies, prophylactic vaccines, molecular therapies, oncology, research and development, manufacturing

Funding

Total Rounds

Last Round

Tue Feb 07 2023

Last Round Series

Post IPO equity

Last Round Raised

$ 250,000,000

CureVac Company Contacts

CureVac Add to my CRM

CureVac